Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

1.7K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.7K
Seizures: Classification01:13

Seizures: Classification

2.4K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
2.4K
REM Sleep Behavior Disorder01:15

REM Sleep Behavior Disorder

2.7K
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
2.7K
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

2.3K
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
2.3K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

1.2K
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.2K
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

1.0K
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
1.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ophthalmic involvement in VEXAS syndrome and its influence on mortality: insights from the international AIDA network registry.

Frontiers in immunology·2026
Same author

Expanding the ABCA2-associated neurodevelopmental phenotype.

HGG advances·2026
Same author

Evidence of Physiological Comodulation During Human-Animal Interaction: A Systematic Review.

Annals of the New York Academy of Sciences·2026
Same author

Microbiota-gut-brain axis and treatment resistance in epilepsy: a multicentre prospective study protocol (CARE).

BMJ open·2026
Same author

The perfect storm: autoinflammation, metabolic stress, and thrombolysis in bilateral carotid dissection-a case report.

Journal of neurology·2026
Same author

Electrographic-only seizures and status epilepticus in neonates with Tuberous Sclerosis Complex.

Pediatric research·2026

Related Experiment Video

Updated: Apr 16, 2026

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
09:57

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization

Published on: September 20, 2024

3.9K

Epilepsy in Rett syndrome--lessons from the Rett networked database.

Andreea Nissenkorn1, Rachel S Levy-Drummer, Ori Bondi

  • 1Pediatric Neurology Unit and Rett National Center, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel HaShomer, Israel; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.

Epilepsia
|March 20, 2015
PubMed
Summary

Specific MECP2 gene mutations influence epilepsy in Rett syndrome, unrelated to overall disease severity. Understanding these distinct mutation effects is key to advancing knowledge of epileptogenesis in this neurodevelopmental disorder.

Keywords:
DatabaseMECP2Preserved speech variantSeizure

More Related Videos

Multi-system Monitoring for Identification of Seizures, Arrhythmias and Apnea in Conscious Restrained Rabbits
10:25

Multi-system Monitoring for Identification of Seizures, Arrhythmias and Apnea in Conscious Restrained Rabbits

Published on: March 27, 2021

6.8K
Preparation and Implantation of Electrodes for Electrically Kindling VGAT-Cre Mice to Generate a Model for Temporal Lobe Epilepsy
09:29

Preparation and Implantation of Electrodes for Electrically Kindling VGAT-Cre Mice to Generate a Model for Temporal Lobe Epilepsy

Published on: August 17, 2021

3.0K

Related Experiment Videos

Last Updated: Apr 16, 2026

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
09:57

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization

Published on: September 20, 2024

3.9K
Multi-system Monitoring for Identification of Seizures, Arrhythmias and Apnea in Conscious Restrained Rabbits
10:25

Multi-system Monitoring for Identification of Seizures, Arrhythmias and Apnea in Conscious Restrained Rabbits

Published on: March 27, 2021

6.8K
Preparation and Implantation of Electrodes for Electrically Kindling VGAT-Cre Mice to Generate a Model for Temporal Lobe Epilepsy
09:29

Preparation and Implantation of Electrodes for Electrically Kindling VGAT-Cre Mice to Generate a Model for Temporal Lobe Epilepsy

Published on: August 17, 2021

3.0K

Area of Science:

  • Neuroscience
  • Genetics
  • Pediatrics

Background:

  • Rett syndrome is a severe X-linked neurodevelopmental disorder caused by MECP2 gene mutations.
  • Epilepsy is a common and significant symptom, but genotype-phenotype correlations remain unclear.
  • A large cohort analysis is needed to clarify the relationship between MECP2 mutations and epilepsy characteristics.

Purpose of the Study:

  • To investigate the correlation between specific MECP2 gene mutations and epilepsy in Rett syndrome patients.
  • To determine if mutation type influences epilepsy prevalence, onset, and severity.
  • To explore potential site-specific effects of MECP2 mutations on epileptic pathways.

Main Methods:

  • Analysis of data from 1,248 female patients in the Rett Syndrome Networked Database.
  • Collection of phenotypic and genotypic data, including epilepsy onset, severity, and seizure types.
  • Statistical analysis using logistic regression and Kaplan-Meier survival curves.

Main Results:

  • Epilepsy affected 68.1% of patients; 32.6% had uncontrolled seizures.
  • Younger age of epilepsy onset correlated with increased epilepsy severity.
  • Specific mutations (p.R133C, p.R255X, p.T158M, p.C306C) showed varying risks for epilepsy and/or severe epilepsy, independent of general Rett phenotype severity.

Conclusions:

  • MECP2 mutations differentially impact epilepsy in Rett syndrome, irrespective of overall disease severity.
  • Findings suggest a potential site-specific role of MeCp2 in epileptic pathways.
  • Further research into these mechanisms is crucial for understanding epileptogenesis in Rett syndrome.